Eyepoint End Period Cash Flow from 2010 to 2024

EYPT Stock  USD 7.94  0.31  3.76%   
Eyepoint Pharmaceuticals End Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. From the period from 2010 to 2024, Eyepoint Pharmaceuticals End Period Cash Flow quarterly data regression had r-value of  0.79 and coefficient of variation of  142.66. View All Fundamentals
 
End Period Cash Flow  
First Reported
2007-06-30
Previous Quarter
90.8 M
Current Value
80 M
Quarterly Volatility
57.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eyepoint Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyepoint Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 440.8 K, Interest Expense of 1.6 M or Total Revenue of 48.3 M, as well as many indicators such as Price To Sales Ratio of 18.09, Dividend Yield of 0.0 or PTB Ratio of 3.13. Eyepoint financial statements analysis is a perfect complement when working with Eyepoint Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Eyepoint Pharmaceuticals Correlation against competitors.
For more information on how to buy Eyepoint Stock please use our How to Invest in Eyepoint Pharmaceuticals guide.

Latest Eyepoint Pharmaceuticals' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Eyepoint Pharmaceuticals over the last few years. It is Eyepoint Pharmaceuticals' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eyepoint Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Eyepoint End Period Cash Flow Regression Statistics

Arithmetic Mean69,957,264
Geometric Mean25,667,002
Coefficient Of Variation142.66
Mean Deviation76,171,479
Median19,121,000
Standard Deviation99,800,650
Sample Variance9960.2T
Range294.5M
R-Value0.79
Mean Square Error4037.6T
R-Squared0.62
Significance0.0005
Slope17,622,426
Total Sum of Squares139442.4T

Eyepoint End Period Cash Flow History

2024295.3 M
2023281.3 M
202295.8 M
2021178.7 M
202045.1 M
201922.4 M
201838.9 M

About Eyepoint Pharmaceuticals Financial Statements

Eyepoint Pharmaceuticals shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Eyepoint Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Eyepoint Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Eyepoint Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow281.3 M295.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eyepoint Stock Analysis

When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.